e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 21

Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model

Anna Katri; Aneta Dąbrowska; Henrik Löfvall; Ming Ding; M.A. Karsdal; Kim Vietz Andreassen; Christian S. Thudium; Kim Henriksen · 2019 · Arthritis Research & Therapy

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Pain is a debilitating symptom of rheumatoid arthritis (RA), caused by joint inflammation and cartilage and bone destruction. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat pain and inflammation in RA, but are not disease-modifying and do not prevent joint destruction when administered alone. KBPs (Key Bioscience peptides) are synthetic peptides based on salmon calcitonin and are expected to inhibit bone resorption and to be chondroprotective. In this study, we investigated if combining a standard of care NSAID (naproxen) with a KBP resulted in improvement in pain

Abstract by Anna Katri; Aneta Dąbrowska; Henrik Löfvall; Ming Ding; M.A. Karsdal; Kim Vietz Andreassen; Christian S. Thudium; Kim Henriksen, Arthritis Research & Therapy (2019) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1186/s13075-019-1819-9